DETECTION OF TUMOR RESPONSE TO CHEMOTHERAPY BY H-1 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY - EFFECT OF 5-FLUOROURACIL ON LACTATE LEVELS IN RADIATION-INDUCED FIBROSARCOMA-1 TUMORS
Eo. Aboagye et al., DETECTION OF TUMOR RESPONSE TO CHEMOTHERAPY BY H-1 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY - EFFECT OF 5-FLUOROURACIL ON LACTATE LEVELS IN RADIATION-INDUCED FIBROSARCOMA-1 TUMORS, Cancer research, 58(5), 1998, pp. 1063-1067
The aim of this study was to evaluate the ability of noninvasive H-1 m
agnetic resonance spectroscopic imaging to detect the response of radi
ation-induced fibrosarcoma 1 tumors to treatment with 5-fluorouracil (
5-FU). Parallel magnetic resonance studies of tumor extracts and assay
s of apoptosis and necrosis in tumor sections were performed to elucid
ate the mechanism underlying the changes detected in spectra in vivo.
Cell death in tumors after a single dose of 5-FU (165 mg/kg, i.p.) was
characterized by increased apoptosis, decreased necrotic fraction, an
d tumor shrinkage within 48 h. No significant change in normalized tri
methylamine and lactate levels was observed during 3 days of untreated
tumor growth. Following treatment with 5-FU, normalized intensities o
f both trimethylamine and lactate decreased significantly from pretrea
tment levels within 24 h and continued to decline at 48 h, The decreas
e in lactate levels determined by spectroscopic imaging in vivo was al
so observed in perchloric acid extracts of radiation-induced fibrosarc
oma 1 tumors, Possible mechanisms for the decrease of tumor lactate le
vels include increased blood flow and decreased glycolytic rate, Unlik
e lactate, changes in normalized trimethylamine levels observed in viv
o were not observed in tumor extracts, The mechanism underlying the an
omalous decrease in the in vivo trimethylamine level is under investig
ation, These findings demonstrate that lactate is a reliable and sensi
tive indirect indicator of response to 5-FU in at least one tumor mode
l and point to the possible clinical utility of this resonance as an i
ndex of clinical tumor response to chemotherapy.